CeriBell, Inc.
CBLLNASDAQHealthcare● Active
$18.28
+$0.03(+0.14%)
Market Cap$693402843
P/E Ratio—
52W High$24.33
52W Low$10.85
CeriBell, Inc. (CBLL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CBLL · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.52
Est. -$0.39 · -33.3%
Revenue
$0.03B
Est. $0.03B · +1.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
CBLL reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.45 | — | — | — | $0.03B | — |
| ▼ Q2 FY2026 | May 11, 2026 | -$0.39 | -$0.52 | -33.3% | $0.03B | $0.03B | +1.6% |
| ▲ Q1 FY2026 | Feb 24, 2026 | -$0.43 | -$0.36 | +16.3% | $0.02B | $0.02B | +3.6% |
| ▲ Q4 FY2025 | Nov 4, 2025 | -$0.43 | -$0.37 | +13.9% | $0.02B | $0.02B | -5.7% |
| ▲ Q3 FY2025 | Aug 5, 2025 | -$0.40 | -$0.38 | +5.0% | $0.02B | $0.02B | -2.6% |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.43 | -$0.36 | +16.3% | $0.02B | $0.02B | -0.3% |
| ▼ Q1 FY2025 | Feb 25, 2025 | -$0.32 | -$0.40 | -25.0% | $0.02B | $0.02B | -4.0% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.82 | -$1.85 | -125.6% | $0.02B | $0.02B | -2.0% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.45
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Miss
EPS Actual
-$0.52
EPS Est.
-$0.39
EPS Surpr.
-33.3%
Revenue
$0.03B
Q1 FY2026
Feb 24, 2026Beat
EPS Actual
-$0.36
EPS Est.
-$0.43
EPS Surpr.
+16.3%
Revenue
$0.02B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
-$0.37
EPS Est.
-$0.43
EPS Surpr.
+13.9%
Revenue
$0.02B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
-$0.38
EPS Est.
-$0.40
EPS Surpr.
+5.0%
Revenue
$0.02B
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.36
EPS Est.
-$0.43
EPS Surpr.
+16.3%
Revenue
$0.02B
Q1 FY2025
Feb 25, 2025Miss
EPS Actual
-$0.40
EPS Est.
-$0.32
EPS Surpr.
-25.0%
Revenue
$0.02B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$1.85
EPS Est.
-$0.82
EPS Surpr.
-125.6%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q3 FY2028 | $-0.19 | $-0.18 | $-0.18 | 1 |
| Q2 FY2028 | $-0.21 | $-0.20 | $-0.20 | 1 |
| Q1 FY2028 | $-0.23 | $-0.23 | $-0.22 | 1 |
| Q4 FY2027 | $-0.24 | $-0.24 | $-0.23 | 1 |
| Q3 FY2027 | $-0.28 | $-0.28 | $-0.27 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 11, 2026 | -33.3% | $20.20 | $20.06 | -0.69% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +16.3% | $19.99 | $19.90 | -0.45% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +13.9% | $11.34 | $10.92 | -3.70% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +5.0% | $15.23 | $15.08 | -0.98% |
| ▲ Q2 FY2025 | May 8, 2025 | +16.3% | $16.01 | $17.10 | +6.81% |
| ▼ Q1 FY2025 | Feb 25, 2025 | -25.0% | $25.43 | $25.54 | +0.43% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -125.6% | $28.90 | $28.85 | -0.17% |
| — Q4 FY2024 | Oct 11, 2024 | — | No price data | $25.00 | — |
Q2 FY2026-0.69%
Report Date
May 11, 2026
EPS Beat/Miss
-33.3%
Price Before
$20.20
Price After
$20.06
Q1 FY2026-0.45%
Report Date
Feb 24, 2026
EPS Beat/Miss
+16.3%
Price Before
$19.99
Price After
$19.90
Q4 FY2025-3.70%
Report Date
Nov 4, 2025
EPS Beat/Miss
+13.9%
Price Before
$11.34
Price After
$10.92
Q3 FY2025-0.98%
Report Date
Aug 5, 2025
EPS Beat/Miss
+5.0%
Price Before
$15.23
Price After
$15.08
Q2 FY2025+6.81%
Report Date
May 8, 2025
EPS Beat/Miss
+16.3%
Price Before
$16.01
Price After
$17.10
Q1 FY2025+0.43%
Report Date
Feb 25, 2025
EPS Beat/Miss
-25.0%
Price Before
$25.43
Price After
$25.54
Q4 FY2024-0.17%
Report Date
Nov 12, 2024
EPS Beat/Miss
-125.6%
Price Before
$28.90
Price After
$28.85
Q4 FY2024—
Report Date
Oct 11, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$25.00
Avg Beat Reaction+0.42%
Avg Miss Reaction-0.14%
Beat Rate4 / 8 quarters
Largest Move+6.81% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CBLL ends December
CeriBell, Inc. (CBLL) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.52 — missing the analyst consensus of $-0.39 by -33.3%. The next CBLL earnings date is expected around September 1, 2026.
Each quarter, investors track CBLL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CBLL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CBLL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CBLL earnings · 5 questionsCeriBell, Inc.'s next earnings report is expected around September 1, 2026. CBLL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CBLL historically reports after market close (AMC).
CBLL earnings datewhen is CBLL earningsCBLL next earnings datewhen does CBLL report earningsCBLL earnings calendar
▸ Source: FMP · CeriBell, Inc. SEC filings · US GAAP · CeriBell, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026